Log in
Enquire now
‌

US Patent 11504062 Patient monitor placement indicator

Patent 11504062 was granted and assigned to Masimo on November, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Masimo
Masimo
Date Filed
February 3, 2020
Date of Patent
November 22, 2022
Patent Applicant
Masimo
Masimo
Patent Application Number
16780762
Patent Citations
‌
US Patent 10058275 Multipurpose sensor port
‌
US Patent 10064562 Variable mode pulse indicator
‌
US Patent 10086138 Autonomous drug delivery system
‌
US Patent 10092200 Plethysmograph variability processor
‌
US Patent 10092249 Robust alarm system
‌
US Patent 10098550 Plethysmographic respiration rate detection
‌
US Patent 10098591 Physiological parameter system
‌
US Patent 10098610 Physiological acoustic monitoring system
‌
US Patent 10111591 Real-time monitoring systems and methods in a healthcare environment
‌
US Patent 10123726 Configurable physiological measurement system
•••
Patent Citations Received
‌
US Patent D1039997 Biological sensor module
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11504062
Patent Primary Examiner
‌
Hoi C Lau
CPC Code
‌
A61B 5/1118
‌
A61B 5/1127
‌
A61B 5/14551
‌
A61B 5/14532
‌
A61B 5/14552
‌
A61B 5/061
‌
A61B 5/06
‌
A61B 5/08
‌
A61B 5/1072
‌
A61B 5/1116
•••

Find more entities like US Patent 11504062 Patient monitor placement indicator

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.